Meeting
2012 Gastrointestinal Cancers Symposium
Association of peripheral blood guanylyl cyclase c (GCC) expressions with prognostic parameters and response to therapy in patients with colorectal cancer.
Authors
Celalettin Camci
Gaziantep University Medical Faculty, Medical Oncology Department, Gaziantep, Turkey
Celalettin Camci , Alper Sevinc , Akif Sahin , Mehmet Emin Kalender , Serdar Oztuzcu , Ozlem nuray Sever , Esma Ozyazgan , Abdullah Tuncay Demiryurek
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
General Poster Session C: Cancers of the Colon and Rectum
Track
Cancers of the Colon, Rectum, and Anus
Sub Track
Translational Research
Citation
J Clin Oncol 30, 2012 (suppl 4; abstr 508)
DOI
10.1200/jco.2012.30.4_suppl.508
Abstract #
508
Poster Bd #
C31
Abstract Disclosures
Similar Posters
Poster
2017 Gastrointestinal Cancers Symposium
Prospective, multi-center study of 5-fluorouracil (5-FU) therapeutic drug management (TDM) in metastatic colorectal cancer (mCRC) patients treated in routine clinical practice.
First Author: Salvatore J. Salamone
Poster
2019 Gastrointestinal Cancers Symposium
CEA response at four weeks as an early predictor for outcomes in patients (pts) with metastatic colorectal cancer (mCRC) treated with first-line cetuximab-based chemotherapy: A STEP-analysis in the JACCRO CC-05/06 trials.
First Author: Yu Sunakawa
Poster
2018 Gastrointestinal Cancers Symposium
BEACON CRC study safety lead-in (SLI) in patients with BRAFV600E metastatic colorectal cancer (mCRC): Efficacy and tumor markers.
First Author: Eric Van Cutsem
Poster
2018 Gastrointestinal Cancers Symposium
Serial monitoring of circulating tumor DNA in patients with metastatic colorectal cancer to predict the therapeutic response.
First Author: Jianfeng Zhou